APA (7th ed.) Citation

Lee, J., Choi, Y. E., Kim, S., Han, J., & Goh, S. (2021). ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί. MDPI AG.

Chicago Style (17th ed.) Citation

Lee, Jeon-Soo, Young Eun Choi, Sunshin Kim, Ji-Youn Han, and Sung-Ho Goh. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί. MDPI AG, 2021.

MLA (8th ed.) Citation

Lee, Jeon-Soo, et al. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί. MDPI AG, 2021.